There are 859 resources available
State of the art locoregional therapy for CNS metastases in metastatic HER2+ breast cancer
Presenter: Srinivas Chilukuri
Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer
Resources:
Slides
Webcast
Immunotherapy in microsatellite stable (MSS) luminal gastrointestinal cancers
Presenter: Hanneke van Laarhoven
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast
Role of local treatment
Presenter: Shankar Siva
Session: Non-small cell lung cancer (NSCLC) treatment options after chemo-immuno failure
Resources:
Slides
Webcast
Pragmatic approach to treatment selection in metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Ravindran Kanesvaran
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Emerging systemic therapy options for CNS disease in HER2+ metastatic breast cancer
Presenter: Soo Chin Lee
Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Webcast
Use of PARP inhibitors in prostate cancer: Current data and future directions
Presenter: Arun Azad
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
General discussion and conclusions
Presenter: All Speakers
Session: Radiation oncology session 2 - Radiotherapy 2023: Optimal management and future
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Non-small cell lung cancer (NSCLC) treatment options after chemo-immuno failure
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer
Resources:
Webcast